Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
51,260,756
-
Share change
-
-613,477
-
Total reported value
-
$771,636,682
-
Put/Call ratio
-
77%
-
Price per share
-
$15.05
-
Number of holders
-
235
-
Value change
-
-$165,775,978
-
Number of buys
-
129
-
Number of sells
-
151
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2024
As of 30 Sep 2024,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,260,756 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Pacer Advisors, Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., DIMENSIONAL FUND ADVISORS LP, Doma Perpetual Capital Management LLC, MORGAN STANLEY, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
235
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.